Skip to content
Screener

Total Revenue at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$39K+388%
Marriott International logo
Marriott InternationalMAR
$1.4B+12.1%
Biogen logo
BiogenBIIB
$963.3M-13.0%
PTH
Pelthos TherapeuticsPTHS
$10.67M—
Life Time Group Holdings logo
Life Time Group HoldingsLTH
$837.4M+13.8%
iRadimed logo
iRadimedIRMD
$15.39M+18.7%

Segments

By product

See full
Dried Distillers Grains$24.16M+13.7%
Distillers Corn Oil$17.59M+40.6%
Modified Distillers Grains$811K-35.2%
Other$91K+203%
Derivative Financial Instrument Gains Losses$62K-69.2%

By segment

See full
Ethanol And By Products$501.79M—
Equity Method Ethanol Investment-$333.3M—

Other financials

Income statement

See full
Gross profit$34.9M+144%
Net income$48.1M+298%
EPS (diluted)$1.06+382%

Balance sheet

See full
Cash & equivalents$91.3M-62.1%
Total debt$18.3M-27.0%
Total equity$673.6M+23.4%
Total assets$856.5M+22.2%

Cash flow

See full
Operating cash flow$40.1M+146%
CapEx$23.3M+6.0%
Free cash flow$16.8M+392%

Valuation

See full
Market cap$1.44B+40.5%
Enterprise value$1.37B+68.8%
P/E8.8×-4.0×
P/S2.2×+0.6×

Profitability

See full
Gross margin18.4%+5.2pp
Net margin25%+12.6pp
FCF margin10.4%—

Returns & leverage

See full
Return on equity27%+12.2pp
Debt / equity0×0.0×
Current ratio6.9×-3.6×

Where this comes from

Reported directly by REX American Resources in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: REX American Resources’s 10-Q, filed September 3, 2026.

Filed
Sep 3, 2026, 1:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000930413-26-002814
Line itemThree Months Ended July 31, 2026Three Months Ended July 31, 2025Six Months Ended July 31, 2026Six Months Ended July 31, 2025
Net sales and revenue$168,493$158,563$324,992$316,903
Production tax credit income18,410-25,959-
Cost of sales (includes $21,243 and $29,004 with related parties for the three months ended July 31, 2026 and 2025, respectively, and $40,083 and $53,853 with related parties for the six months ended July 31, 2026 and 2025, respectively.)133,603144,244268,580288,242
Gross profit53,30014,31982,37128,661
Selling, general and administrative expenses(15,622)(6,201)(25,350)(12,145)
Equity in income of unconsolidated affiliates7,19589110,7611,897
Interest and other income, net3,2453,0886,4517,310
Income before income taxes48,11812,09774,23325,723

Item 1. *Financial Statements

FAQ

What is REX American Resources's total revenue?
REX American Resources (REX) reported total revenue of $168.49M in Q2 2026.
How has REX American Resources's total revenue changed year-over-year?
REX American Resources's total revenue increased by 6.3% year-over-year, from $158.56M to $168.49M.
What is the long-term trend for REX American Resources's total revenue?
Over 4 years (2021 to 2025), REX American Resources's total revenue has grown at a -4.3% compound annual growth rate (CAGR), from $774.8M to $650.49M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about REX American Resources's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude